Le produit a bien été ajouté au panier.

discount label
H-VMAPRTLVL^-OH
Vue en 3D

Biosynth logo

H-VMAPRTLVL^-OH

Ref. 3D-PP48718

Taille indéfinieÀ demander
Livraison estimée en/au États-Unis, le mardi 3 décembre 2024

Informations sur le produit

Nom :
H-VMAPRTLVL^-OH
Description :

Peptide H-VMAPRTLVL^-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-VMAPRTLVL^-OH include the following: The human major histocompatibility complex class Ib molecule HLA-E binds signal sequence-derived peptides with primary anchor residues at positions 2 and 9 V Braud , E Yvonne Jones - European journal of , 1997 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/eji.1830270517 HLA-E: a novel player for histocompatibility T Kraemer, R Blasczyk - Journal of Immunology , 2014 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1155/2014/352160 Peptide-specific recognition of human cytomegalovirus strains controls adaptive natural killer cells Q Hammer , T Ruckert , EM Borst, J Dunst - Nature , 2018 - nature.comhttps://www.nature.com/articles/s41590-018-0082-6 Human T cell receptor-mediated recognition of HLA-E P Garcaca­a, M Llano , AB Heredia - European journal of , 2002 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/1521-4141(200204)32:4%3C936::AID-IMMU936%3E3.0.CO;2-M HLA-E surface expression depends on binding of TAP-dependent peptides derived from certain HLA class I signal sequences N Lee, DR Goodlett , A Ishitani, H Marquardt - The Journal of , 1998 - journals.aai.orghttps://journals.aai.org/jimmunol/article/160/10/4951/69107 Alternative peptide repertoire of HLA-E reveals a binding motif that is strikingly similar to HLA-A2 MH Lampen, C Hassan, M Sluijter, A Geluk - Molecular , 2013 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0161589012003562 Peptides with dual binding specificity for HLA-A2 and HLA-E are encoded by alternatively spliced isoforms of the antioxidant enzyme peroxiredoxin 5 M Sensi, G Pietra , A Molla, G Nicolini - International , 2009 - academic.oup.comhttps://academic.oup.com/intimm/article-abstract/21/3/257/683513 Soluble HLA-I/peptide monomers mediate antigen-specific CD8 T cell activation through passive peptide exchange with cell-bound HLA-I molecules M Allard , R Oger, H Benlalam, L Florenceau - The Journal of , 2014 - journals.aai.orghttps://journals.aai.org/jimmunol/article/192/11/5090/92443 Natural killer cell receptors regulate responses of HLA-E-restricted T cells LC Sullivan , THO Nguyen , CM Harpur - Science , 2021 - science.orghttps://www.science.org/doi/abs/10.1126/sciimmunol.abe9057 Expression of the mouse MHC class Ib H2-T11 gene product, a paralog of H2-T23 (Qa-1) with shared peptide-binding specificity L Chen , E Reyes-Vargas, H Dai, H Escobar - The Journal of , 2014 - journals.aai.orghttps://journals.aai.org/jimmunol/article/193/3/1427/108808 Involvement of position-147 for HLA-E expression K Matsunami, T Kusama, E Okura, R Shirakura - Biochemical and , 2006 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0006291X06014598 Modulation of the leader peptide sequence of the HLA-E gene up-regulates its expression and down-regulates natural killer cell-mediated swine endothelial cell lysis1 K Matsunami, S Miyagawa, R Nakai, M Yamada - , 2002 - journals.lww.comhttps://journals.lww.com/transplantjournal/fulltext/2002/05270/Modulation_of_the_leader_peptide_sequence_of_the.10.aspx Analysis of HLA-E peptide-binding specificity and contact residues in bound peptide required for recognition by CD94/NKG2 JD Miller, DA Weber, C Ibegbu, J Pohl - The Journal of , 2003 - journals.aai.orghttps://journals.aai.org/jimmunol/article/171/3/1369/973 Analysis of HLA-E Peptide-Binding Specificity JD Altman , PE Jensen, JD Miller, DA Weber, C Ibegbu - J Immunol, 2003 - academia.eduhttps://www.academia.edu/download/40078875/Analysis_of_HLA-E_peptide-binding_specif20151116-18223-1t98kb0.pdf A novel and efficient approach to high-throughput production of HLA-E/peptide monomer for T-cell epitope screening J Vaurs , G Douchin, K Echasserieau, R Oger - Scientific Reports, 2021 - nature.comhttps://www.nature.com/articles/s41598-021-96560-9 Peptide binding characteristics of the non-classical class Ib MHC molecule HLA-E assessed by a recombinant random peptide approach J Stevens , E Joly , J Trowsdale , GW Butcher - BMC immunology, 2001 - Springerhttps://link.springer.com/article/10.1186/1471-2172-2-5 Structural basis for a major histocompatibility complex class Ib-restricted T cell response HL Hoare, LC Sullivan , G Pietra , CS Clements - Nature , 2006 - nature.comhttps://www.nature.com/articles/ni1312 HLA-E-restricted recognition of cytomegalovirus-derived peptides by human CD8+ cytolytic T lymphocytes G Pietra , C Romagnani, P Mazzarino - Proceedings of the , 2003 - National Acad Scienceshttps://www.pnas.org/doi/abs/10.1073/pnas.1834449100 HLA-E and HLA-E-bound peptides: recognition by subsets of NK and T cells G Pietra , C Romagnani, L Moretta - Current , 2009 - ingentaconnect.comhttps://www.ingentaconnect.com/content/ben/cpd/2009/00000015/00000028/art00014 Purification and HPLC-MS analysis of a naturally processed HCMV-derived peptide isolated from the HEK-293T/HLA-E+/Ul40+ cell transfectants and presented at the E Millo, G Pietra , A Armirotti , P Vacca - Journal of , 2007 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0022175907000373 HLA-E restricted cytomegalovirus UL40 peptide polymorphism may represent a risk factor following congenital infection D Tarrago Asensio, I Gonzalez-Jimenez - 2022 - repisalud.isciii.eshttps://repisalud.isciii.es/handle/20.500.12105/15972 HLA-E restricted cytomegalovirus UL40 peptide polymorphism may represent a risk factor following congenital infection D Tarrago, I Gonzalez, MF Gonzalez-Escribano - BMC genomics, 2022 - Springerhttps://link.springer.com/article/10.1186/s12864-022-08689-0 HLA-E-restricted recognition of human cytomegalovirus by a subset of cytolytic T lymphocytes C Romagnani, G Pietra , M Falco , P Mazzarino - Human immunology, 2004 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0198885904000370 The complex HLA-E-nonapeptide in Behaca§et disease acaL Casta-Nacaºaca±ez, MA Montes-Cano - Frontiers in , 2023 - frontiersin.orghttps://www.frontiersin.org/articles/10.3389/fimmu.2023.1080047/full

Avis:
Nos produits sont destinés uniquement à un usage en laboratoire. Pour tout autre usage, veuillez nous contacter.
Marque:
Biosynth
Stockage à long terme :
Notes :

Propriétés chimiques

MDL:
Point de fusion :
Point d'ébullition :
Point d'éclair :
Densité :
Concentration :
EINECS :
Merck :
Code SH :

Informations sur les risques

Numéro ONU :
EQ:
Classe :
Phrases R :
Phrases S :
Transport aérien interdit :
Informations sur les risques :
Groupe d'emballage :
LQ :

Question d’ordre technique sur : 3D-PP48718 H-VMAPRTLVL^-OH

Veuillez plutôt utiliser le panier afin de demander un devis ou passer commande

Si vous souhaitez demander un devis ou passer commande, veuillez plutôt ajouter les produits souhaités à votre panier, puis demander un devis ou passer commande à partir de votre panier. C'est une méthode plus rapide, plus économique, et vous pourrez bénéficier des remises disponibles ainsi que d'autres avantages

* Champ obligatoire
Bienvenue chez CymitQuimica !Nous utilisons des cookies pour améliorer votre visite. Nous n’incluons pas de publicité.

Veuillez consulter notre Politique de Cookies pour plus de détails ou ajustez vos préférences dans "Configurer".